RENNANO

Welcome to the Brand page for “RENNANO”, which is offered here for Vaccines; pharmaceutical preparations for the treatment of immune system related diseases and disorders; medicines for the treatment of cancer; diagnostic preparations for medical purposes; biochemical medicines for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; medicines for human purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; drugs for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; biological preparations for medical purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases; active pharmaceutical ingredients being chemical and biological preparations for pharmaceutical purposes, antibodies for the treatment of human and animal diseases; diagnostic preparations for medical and veterinary purposes; dietetic preparations adapted for medical use; medicines for veterinary purposes for the treatment of tumors, infectious diseases, inflammation and autoimmune diseases;live trees; live plants; live animals; poultry, live; pigs, live; hamsters, live; live laboratory animals; plant seeds; fodder; litter for animals;conducting early evaluation in the field of new pharmaceutical products; development of products for others; consulting services in the field of technology development in the fields of pharmaceutical research and development; research and development of new products; pharmaceutical research services; quality control inspection in the field of pharmaceutical research and development; biochemical research and analysis; research and development services in the field of antibodies; medical and scientific research, conducting clinical trials for others; biological research; development of pharmaceutical preparations and medicines; product testing; pharmaceutical products development services; evaluation of pharmaceuticals; technological research, pharmaceutical research;.

Its status is currently believed to be active. Its class is unavailable. “RENNANO” is believed to be currently owned by “Biocytogen Pharmaceuticals (Beijing) Co., Ltd.”